Optimizing Vancomycin Therapy for MRSA Infections Optimizing Vancomycin Therapy for MRSA Infections


Optimizing Vancomycin Therapy for MRSA Infections: A Case-Based Best Practice Approach

Tuesday, August 16, 2022

There’s a better way to optimize vancomycin dosing for MRSA pneumonia and other infectious diseases. Join our case-based webinar to learn more about improving quality and lowering costs this fall and winter for patients who are being treated with Vancomycin.

Our presenters, Sarah Burgdorf MD, PhD, Mike Rinaldi, PharmD, and Sharmeen Roy, PharmD, BCPS from IDC and DoseMeRx will also address how to improve overall antimicrobial stewardship communication between clinical team members.

You might also like…

ID Connect Expands Clinical Decision Support within UPMC and Continues to Deliver ID Care Quality Improvements and Cost Reductions

Connect with us at ID Week 2022

KLAS Research

KLAS Spotlight: Infectious Disease Connect


Receive Your Copy of IDC’s Information

Please fill out the form below to access this content.

Thank you, the form submit was successful!